|
시장보고서
상품코드
1975182
유세포분석 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)Global Flow Cytometry Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
유세포분석 시장 규모는 2025년 61억 4,000만 달러에서 2026-2034년에 CAGR 8.46%로 성장하며, 2034년에는 127억 5,000만 달러에 달할 것으로 예측되고 있습니다.
임상 진단, 암 연구, 면역학, 신약개발 분야에서의 응용 확대에 따라 세계 유세포분석 시장은 꾸준히 성장하고 있습니다. 유세포분석 기술은 신속한 세포 분석, 바이오마커 검출, 질병 모니터링을 가능하게 하여 현대 의료 시스템에서 없어서는 안 될 필수적인 존재가 되었습니다. 특히 암과 자가면역질환을 비롯한 만성질환의 유병률 증가는 병원, 연구소, 생명공학 기업에서 첨단 진단 및 연구 툴에 대한 수요를 크게 증가시키고 있습니다.
주요 성장 요인으로는 다변량 분석 기술의 발전, 데이터 분석을 위한 인공지능(AI)의 통합, 바이오의약품 연구개발(R&D) 활동의 확대 등을 꼽을 수 있습니다. 정부 및 민간 기관이 생명과학 연구에 많은 투자를 하고 있는 것도 도입을 더욱 촉진하고 있습니다. 정밀의료와 맞춤 치료의 중요성이 높아지면서 전 세계에서 세포 기반 분석, 백신 개발, 면역치료 연구에 유세포분석의 활용이 증가하고 있습니다.
기술 혁신으로 장비의 감도, 자동화, 휴대성이 향상되고 있으므로 미래 전망은 매우 유망합니다. 신흥 국가에서는 의료 인프라 투자가 증가하고 있으며, 새로운 매출 기회가 창출되고 있습니다. 또한 세포 및 유전자 치료 연구의 확대는 시장 수요를 더욱 강화할 것입니다. 의료 시스템이 질병의 조기 발견과 첨단 연구 능력을 중시하는 가운데, 유세포분석 시장은 지속적인 장기적 성장을 기록할 것으로 예측됩니다.
목차
제1장 서론
제2장 개요
제3장 시장 변수, 동향, 프레임워크
제4장 세계의 유세포분석 시장 : 기술별
제5장 세계의 유세포분석 시장 : 제품·서비스별
제6장 세계의 유세포분석 시장 : 용도별
제7장 세계의 유세포분석 시장 : 최종사용자별
제8장 세계의 유세포분석 시장 : 지역별
제9장 경쟁 구도
제10장 기업 개요
KSA 26.04.01The Flow Cytometry Market size is expected to reach USD 12.75 Billion in 2034 from USD 6.14 Billion (2025) growing at a CAGR of 8.46% during 2026-2034.
The Global Flow Cytometry Market is expanding steadily due to increasing applications in clinical diagnostics, cancer research, immunology, and drug discovery. Flow cytometry technology enables rapid cell analysis, biomarker detection, and disease monitoring, making it essential in modern healthcare systems. Rising prevalence of chronic diseases, particularly cancer and autoimmune disorders, is significantly boosting demand for advanced diagnostic and research tools across hospitals, research laboratories, and biotechnology companies.
Major growth drivers include advancements in multi-parameter analysis, integration of artificial intelligence for data interpretation, and expanding biopharmaceutical R&D activities. Governments and private institutions are investing heavily in life sciences research, further supporting adoption. The growing importance of precision medicine and personalized therapies is also increasing the use of flow cytometry in cell-based assays, vaccine development, and immunotherapy studies worldwide.
Future prospects remain highly promising as technological innovations enhance instrument sensitivity, automation, and portability. Emerging economies are witnessing rising healthcare infrastructure investments, creating new revenue opportunities. Additionally, the expansion of cell and gene therapy research will further strengthen market demand. As healthcare systems emphasize early disease detection and advanced research capabilities, the flow cytometry market is expected to register consistent long-term growth.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Technology
- Cell-based
- Bead-based
By Products & Services
- Reagents & Consumables
- Flow Cytometry Instruments (Cell Analyzers, Cell Sorters)
- Software
- Services
By Application
- Pharmaceutical & Drug Discovery
- Diagnostics
- Others
By End User
- Hospitals & Diagnostic Labs
- Academic & Research Institutions
- Others
COMPANIES PROFILED
- BD Becton Dickinson and Company, Merck amp Co Inc, Beckman Coulter Inc, Sysmex Corporation, Abbott, Miltenyi Biotec, BioTechne, Agilent Technologies Inc, BioRad Laboratories Inc, Thermo Fisher Scientific
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL FLOW CYTOMETRY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Technology
- 4.2. Cell-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Bead-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL FLOW CYTOMETRY MARKET: BY PRODUCTS & SERVICES 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Products & Services
- 5.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Flow Cytometry Instruments (Cell Analyzers, Cell Sorters) Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL FLOW CYTOMETRY MARKET: BY APPLICATION 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Application
- 6.2. Pharmaceutical & Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL FLOW CYTOMETRY MARKET: BY END USER 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End User
- 7.2. Hospitals & Diagnostic Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Academic & Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL FLOW CYTOMETRY MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Technology
- 8.2.2 By Products & Services
- 8.2.3 By Application
- 8.2.4 By End User
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Technology
- 8.3.2 By Products & Services
- 8.3.3 By Application
- 8.3.4 By End User
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Technology
- 8.4.2 By Products & Services
- 8.4.3 By Application
- 8.4.4 By End User
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Technology
- 8.5.2 By Products & Services
- 8.5.3 By Application
- 8.5.4 By End User
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Technology
- 8.6.2 By Products & Services
- 8.6.3 By Application
- 8.6.4 By End User
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL FLOW CYTOMETRY INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 BD (Becton Dickinson And Company)
- 10.2.2 Merck & Co. Inc
- 10.2.3 Beckman Coulter Inc
- 10.2.4 Sysmex Corporation
- 10.2.5 Abbott
- 10.2.6 Miltenyi Biotec
- 10.2.7 Bio-Techne
- 10.2.8 Agilent Technologies Inc
- 10.2.9 Bio-Rad Laboratories Inc
- 10.2.10 Thermo Fisher Scientific
